Clinical trial
Transvaginal Photobiomodulation for the Treatment of Dyspareunia in Endometriosis Patients: a Randomized Controlled Trial
NCT05540353 is registered in ClinicalTrials.gov with Medstar Health Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Transvaginal Photobiomodulation for the Treatment of Dyspareunia in Endometriosis Patients: a Randomized Controlled Trial
- Lead sponsor
- Medstar Health Research Institute
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- May 2, 2023
- Completion date
- July 1, 2024
- Enrollment
- 6 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.